Net Loss of Oxygenta Pharmaceutical reported to Rs 4.56 crore in the quarter ended June 2023 as against net loss of Rs 1.69 crore during the previous quarter ended June 2022. Sales declined 22.83% to Rs 6.86 crore in the quarter ended June 2023 as against Rs 8.89 crore during the previous quarter ended June 2022.
Particulars | Quarter Ended |
| Jun. 2023 | Jun. 2022 | % Var. |
Sales | 6.86 | 8.89 | -23 |
OPM % | -53.06 | -11.70 | - |
PBDT | -3.93 | -1.29 | -205 |
PBT | -4.43 | -1.69 | -162 |
NP | -4.56 | -1.69 | -170 |